Cargando…

Mature dendritic cell-derived dendrosomes swallow oxaliplatin-loaded nanoparticles to boost immunogenic chemotherapy and tumor antigen-specific immunotherapy

The cytomembrane-derived delivery platform represents a promising biomimetic strategy in oncotherapy. To achieve durable and reliable tumor inhibition, mature dendrosomes (mDs), which were isolated from bone marrow-derived dendritic cells undergoing CT26 tumor antigen (TA) stimulation, were fused wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xing, Ling, Xiang, Xia, Jiaxuan, Zhu, Ying, Zhang, Longlong, He, Yuwei, Wang, Anni, Gu, Guolong, Yin, Bo, Wang, Jianxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941172/ https://www.ncbi.nlm.nih.gov/pubmed/35386340 http://dx.doi.org/10.1016/j.bioactmat.2021.12.020

Ejemplares similares

Synergistic effects of dendrosomal nanocurcumin and oxaliplatin on oncogenic properties of ovarian cancer cell lines by down-expression of MMPs
por: Seyed Hosseini, Elahe, et al.
Publicado: (2023)

Dendrosomal nanocurcumin and p53 overexpression synergistically trigger apoptosis in glioblastoma cells
por: Keshavarz, Reihaneh, et al.
Publicado: (2016)

An investigation of the inhibitory effects of dendrosomal nanocurcumin on Candida albicans and systemic candidiasis in BALB/c mice
por: Katiraee, F, et al.
Publicado: (2016)

Up-regulation of miR-21 decreases chemotherapeutic effect of dendrosomal curcumin in breast cancer cells
por: Esmatabadi, Mohammad Javad Dehghan, et al.
Publicado: (2017)

Smart Design of Nanostructures for Boosting Tumor Immunogenicity in Cancer Immunotherapy
por: Yin, Bohan, et al.
Publicado: (2023)

Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
por: Gao, Jing, et al.
Publicado: (2020)

Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
por: Cheng, Shanshan, et al.
Publicado: (2020)

Transcriptional determinants of tolerogenic and immunogenic states during dendritic cell maturation
por: Vander Lugt, Bryan, et al.
Publicado: (2017)

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
por: Li, Zhilin, et al.
Publicado: (2022)

Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells
por: Tahmasebi Mirgani, Maryam, et al.
Publicado: (2014)

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
por: Lesterhuis, W J, et al.
Publicado: (2010)

Combined Treatment of Dendrosomal-Curcumin and Daunorubicin Synergistically Inhibit Cell Proliferation, Migration and Induce Apoptosis in A549 Lung Cancer Cells
por: Eslami, Seyed Sadegh, et al.
Publicado: (2023)

Immunotherapy with internally inactivated virus loaded dendritic cells boosts cellular immunity but does not affect feline immunodeficiency virus infection course
por: Freer, Giulia, et al.
Publicado: (2008)

Oxaliplatin Induces Immunogenic Cell Death in Human and Murine Laryngeal Cancer
por: Wang, Jingmiao, et al.
Publicado: (2022)

Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy
por: Chung, David J, et al.
Publicado: (2013)

Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells
por: Zhu, Ying, et al.
Publicado: (2022)

Dendrosomal nanocurcumin prevents EBV-associated cell transformation by targeting the lytic cycle genes of the Epstein-Barr virus in the generation of lymphoblastoid cell line
por: Cheragh, Mahboobeh, et al.
Publicado: (2023)

Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibody Treatments
por: Mehmood, Rao Khalid
Publicado: (2014)

Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibodies Perspective
por: Mehmood, Rao Khalid, et al.
Publicado: (2014)

Lentinan Enhances the Function of Oxaliplatin on the Esophageal Tumors by Persuading Immunogenic Cell Death
por: Huo, Xiaolei, et al.
Publicado: (2022)

Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation
por: Sittig, Simone P., et al.
Publicado: (2015)

Photodynamic therapy augments oxaliplatin-induced immunogenic cell death in colorectal cancer
por: Wang, Xiaobo, et al.
Publicado: (2023)

Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy
por: Liu, Hongyu, et al.
Publicado: (2017)

Vitamin C enhances NF-κB-driven epigenomic reprogramming and boosts the immunogenic properties of dendritic cells
por: Morante-Palacios, Octavio, et al.
Publicado: (2022)

Swallowing Lithium Dendrites in All‐Solid‐State Battery by Lithiation with Silicon Nanoparticles
por: Tao, Jianming, et al.
Publicado: (2021)

In Situ Vaccination with Mitochondria‐Targeting Immunogenic Death Inducer Elicits CD8(+) T Cell‐Dependent Antitumor Immunity to Boost Tumor Immunotherapy
por: Wang, Yuxiang, et al.
Publicado: (2023)

Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles
por: Win, S J, et al.
Publicado: (2012)

Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer
por: Arai, Hiroyuki, et al.
Publicado: (2020)

Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma
por: Jessup, J. Milburn, et al.
Publicado: (2019)

Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation
por: Xiao, Zecong, et al.
Publicado: (2022)

Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy
por: Rainone, Veronica, et al.
Publicado: (2016)

mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy
por: Sasaki, Kosuke, et al.
Publicado: (2022)

Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment
por: Xi, Long, et al.
Publicado: (2022)

Chemo-Immunotherapy with Oxaliplatin and Interleukin-7 Inhibits Colon Cancer Metastasis in Mice
por: Gou, Hong-Feng, et al.
Publicado: (2014)

Immunogenic Cell Death Induced by Ginsenoside Rg3: Significance in Dendritic Cell-based Anti-tumor Immunotherapy
por: Son, Keum-joo, et al.
Publicado: (2016)

Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets
por: Romagnoli, Graziela Gorete, et al.
Publicado: (2015)

Retracted: Lentinan Enhances the Function of Oxaliplatin on the Esophageal Tumors by Persuading Immunogenic Cell Death
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer
por: Sersa, Gregor, et al.
Publicado: (2015)

Correction: Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy
por: Rainone, Veronica, et al.
Publicado: (2016)

Small Extracellular Vesicles Loaded with Immunosuppressive miRNAs Leads to an Inhibition of Dendritic Cell Maturation
por: Czernek, Liliana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sb0nvjg4t0css3teph2sccuhd2